(3) Amount of Separate Payment for Diagnostic Radiopharmaceuticals Exceeding the Threshold As discussed in the CY 2025 OPPS/ASC final rule with comment period (89 FR 93955 through 93959), once we determine that the per day cost of a nonpass-through diagnostic radiopharmaceutical exceeds the cost threshold, proposed to be $655 per day for CY 2026, we will then assign that radiopharmaceutical to an APC, making it a specified covered outpatient drug (SCOD) per section 1833(t)(14)(B) of the Act
When applied to the skin, GHK-Cu stimulates key repair functions
Bludau, A., Royer, M., Meister, G., Neumann, I
A 2007 study published in Chemical Research in Toxicology has found that increased exposure to lead may increase the risk of thrombotic events ( 22 )
Since its initial characterization, this compound has attracted considerable scientific attention due to its broad regenerative profile observed in preclinical models